Clinical Trial Update: Directed Ablation of Uterine Fibroids Using a Noninvasive Approach [NA]

View source ↗

Summary

The study provides an update on a noninvasive directed ablation approach for uterine fibroids (uterine leiomyoma) sponsored by Mirabilis Medica.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyoma

Snippet

Sponsor: Mirabilis Medica, Inc. | Conditions: Uterine Leiomyoma | NA | Status: UNKNOWN